Evaluation of soluble expression of recombinant granulocyte macrophage stimulating factor (rGM-CSF) by three different E. coli strains

Sina Soheili,Ali Jahanian-Najafabadi,Vajihe Akbari

DOI: https://doi.org/10.4103/1735-5362.288424

2020-01-01

Research in Pharmaceutical Sciences

Abstract:BACKGROUND AND PURPOSE: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine with a wide range of therapeutic applications although expression of GM-CSF in <i>Escherichia coli</i> (<i>E. coli</i>) usually leads to formation of insoluble aggregates mostly lack biological activity. The aim of this study was to compare the soluble expression level of GM-CSF in three <i>E. coli</i> strains, BL21 (DE3), SHuffle® T7 and Origami™ 2 (DE3).EXPERIMENTAL APPROACH: The effect of different temperatures and inducer concentrations on soluble expression of GM-CSF was evaluated. The soluble GM-CSF was subjected to endotoxin removal and purification using nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography, ultrafiltration. The biological activity of produced GM-CSF was evaluated based on its growth promotion effect on TF-1 cell lines by MTT assay method.FINDINGS / RESULTS: A significant improvement of the soluble yield of GM-CSF (about 30% of GM-CSF was expressed as soluble proteins) was observed when protein expression was induced at 30 °C with 0.5 mM isopropyl β- d-1-thiogalactopyranoside (IPTG) in <i>E. coli</i> Shuffle T7. The soluble GM-CSF with a high purity up to 95 % and specific activity of 1.25 × 10⁴ IU/μg was obtained.CONCLUSION AND IMPLICATIONS: The proposed strategy here can be used to improve the soluble expression of other hard-to-express proteins with similar structural properties (<i>i.e</i>., containing disulfide binds or cysteine).